- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Defining Patient Centric Pharmaceutical Drug Product Design ; day:17 ; month:6 ; year:2016 ; pages:1-9
The AAPS journal / American Association of Pharmaceutical Scientists ; (17.6.2016), 1-9
- Urheber
-
Stegemann, Sven
- Beteiligte Personen und Organisationen
-
Ternik, Robert L.
Onder, Graziano
Khan, Mansoor A.
Riet-Nales, Diana A. Van
SpringerLink (Online service)
- DOI
-
10.1208/s12248-016-9938-6
- URN
-
urn:nbn:de:1111-201606198238
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stegemann, Sven
- Ternik, Robert L.
- Onder, Graziano
- Khan, Mansoor A.
- Riet-Nales, Diana A. Van
- SpringerLink (Online service)
Ähnliche Objekte (12)
Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Defining Cases and Variants for Object-Centric Event Data
Customer-centric product presentations for monoclonal antibodies
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Structural Cheminformatics for Kinase-Centric Drug Design
Defining centric diatoms of most relevant phytoplankton functional groups in deep karst lakes
Primate models in pharmaceutical drug development
Advertising regulations in pharmaceutical markets: Product versus enlightenment
A strategic management perspective on service transition of product-centric firms
An enterprise centric analytical risk assessment framework for new product development
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Defining Cases and Variants for Object-Centric Event Data
Customer-centric product presentations for monoclonal antibodies
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Structural Cheminformatics for Kinase-Centric Drug Design
Defining centric diatoms of most relevant phytoplankton functional groups in deep karst lakes
Primate models in pharmaceutical drug development
Advertising regulations in pharmaceutical markets: Product versus enlightenment
A strategic management perspective on service transition of product-centric firms
An enterprise centric analytical risk assessment framework for new product development
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Defining Cases and Variants for Object-Centric Event Data
Customer-centric product presentations for monoclonal antibodies
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Structural Cheminformatics for Kinase-Centric Drug Design
Defining centric diatoms of most relevant phytoplankton functional groups in deep karst lakes
Primate models in pharmaceutical drug development
Advertising regulations in pharmaceutical markets: Product versus enlightenment
A strategic management perspective on service transition of product-centric firms
An enterprise centric analytical risk assessment framework for new product development